Related Experiment Video
Updated: Aug 19, 2026
Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence
Wieslawa Janaszek-Seydlitz1, Bozena Bucholc, Paulina Gorska
1Department of Sera and Vaccine Evaluation, National Institute of Hygiene, Chocimska 24, Warsaw, Poland. wjanaszek@pzh.gov.pl
Abstract:
The annual incidence of mumps in Poland over the period 1990-2003 was 45-570 per 100,000 population with the epidemic peak every 4-5 years. Till 2003, mumps vaccination has not been included in the part of National Immunisation Program in Poland that comprises the obligatory vaccinations. However, mumps vaccination was recommended by National Health Authority for children at the second year of life and it could be obtained privately. The proportion of vaccinated children has increased by 50% in last years. It has influenced on decreasing of number of notified mumps cases in Poland, on lengthening of inter-epidemic period as well as on drift of infections towards older groups of children. The results of serological survey carried out on 1390 serum samples have indicated, that the proportion of positive serum samples (>11 VE/ml) was only 24.1% for children aged 1-4 years, 45.4% for children aged 5-9 years, 72.5% for age group 10-14 years, and over 85% for persons aged 15-30 years. Epidemiological data and the high proportion of individuals with negative titres of specific mumps IgG antibodies justify the need of introduction of obligatory mass immunisation against mumps in Poland.
Insights
Mumps vaccination is not obligatory in Poland, leading to low antibody levels in many age groups. Increased private vaccination reduced cases but shifted infections to older children, indicating a need for mandatory mumps immunization.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- Mumps incidence in Poland (1990-2003) showed epidemic peaks every 4-5 years.
- Mumps vaccination was not obligatory, though recommended and privately available.
- Recent increases in vaccination rates (50%) impacted mumps epidemiology.
Purpose of the Study:
- To assess the serological status of mumps immunity in Poland.
- To evaluate the impact of vaccination on mumps epidemiology.
- To determine the necessity of introducing obligatory mumps vaccination.
Main Methods:
- Analysis of epidemiological data on mumps incidence (1990-2003).
- Serological survey of 1390 serum samples to determine mumps IgG antibody levels.
- Assessment of vaccination coverage trends.
Main Results:
- Serological survey revealed low mumps antibody prevalence: 24.1% (1-4 yrs), 45.4% (5-9 yrs), 72.5% (10-14 yrs), and >85% (15-30 yrs).
- Increased vaccination correlated with decreased mumps cases and longer inter-epidemic periods.
- Infections shifted towards older children.
Conclusions:
- Low seropositivity indicates insufficient population immunity against mumps.
- Epidemiological trends and serological data support the need for mandatory mumps vaccination in Poland.
- Obligatory mass immunization is recommended to control mumps outbreaks.
More Related Videos
Related Concept Videos
01:17Poliomyelitis
01:29Malaria
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:28Infectious Diseases and Their Occurrence
01:20Chickenpox
01:51Vaccinations